Literature DB >> 8355811

Cerebral amyloid in human prion disease.

R Watanabe1, L W Duchen.   

Abstract

The clinical and neuropathological features of 21 patients with prion disease were reviewed with special reference to the morphology and immunoreactivity of cerebral amyloid. Six cases had a mutation at codon 102 of the prion protein (PrP) gene and in these the characteristic pathology was the formation of multicentric amyloid plaques which were stained with PrP antibody, whereas spongiform changes were absent in one and minimal in two. In one case, with a 216 base-pair insertion in the PrP gene, there was no spongiform encephalopathy (SE) but cerebellar amyloid was a prominent feature of the pathology. One case with a PrP gene mutation at codon 200 had severe SE but no amyloid. Two iatrogenic and 11 sporadic cases had SE and some form of amyloid was identified in all but three. Amyloid angiopathy and senile neuritic plaques, which stained with antibody to beta-protein, were present in familial as well as in sporadic cases, including some who were rather young to be regarded as having Alzheimer's disease. Cerebellar amyloid and degeneration of granule and Purkinje cells were particularly common findings in sporadic as well as in genetically determined cases. This study serves to emphasize the association between prion disease and amyloid deposition in the brain. PrP is a component of some amyloid plaques in a high proportion of cases with inherited prion disease but may also be found in cases of sporadic SE without known mutations or base-pair insertions in the PrP gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355811     DOI: 10.1111/j.1365-2990.1993.tb00435.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  9 in total

1.  Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

2.  The p75 neurotrophin receptor can induce autophagy and death of cerebellar Purkinje neurons.

Authors:  Maria L Florez-McClure; Daniel A Linseman; Charleen T Chu; Phil A Barker; Ron J Bouchard; Shoshona S Le; Tracey A Laessig; Kim A Heidenreich
Journal:  J Neurosci       Date:  2004-05-12       Impact factor: 6.167

3.  Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

4.  Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.

Authors:  E Sarkozi; V Askanas; W K Engel
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

5.  Creutzfeldt-Jakob disease and cerebral amyloid angiopathy.

Authors:  F Gray; F Chrétien; P Cesaro; J Chatelain; P Beaudry; J L Laplanche; J Mikol; J Bell; P Gambetti; J D Degos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Neuropathological changes in striate and extrastriate visual cortex in variant Creutzfeldt-Jakob disease (vCJD).

Authors:  Richard A Armstrong
Journal:  Clin Ophthalmol       Date:  2007-06

7.  PiB Fails to Map Amyloid Deposits in Cerebral Cortex of Aged Dogs with Canine Cognitive Dysfunction.

Authors:  Rikke Fast; Anders Rodell; Albert Gjedde; Kim Mouridsen; Aage K Alstrup; Carsten R Bjarkam; Mark J West; Mette Berendt; Arne Møller
Journal:  Front Aging Neurosci       Date:  2013-12-30       Impact factor: 5.750

8.  Quantitative amyloid imaging using image-derived arterial input function.

Authors:  Yi Su; Tyler M Blazey; Abraham Z Snyder; Marcus E Raichle; Russ C Hornbeck; Patricia Aldea; John C Morris; Tammie L S Benzinger
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

9.  Commentary: Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Isis Nem De Oliveira Souza; Evandro A De-Souza
Journal:  Front Aging Neurosci       Date:  2016-01-21       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.